Participants 29 52 3
non-Hodgkin's lymphomas
Participants 99 271 8
150 patients with favorable subtypes of non-Hodgkin's lymphoma [nodular poorly differentiated lymphocytic (NLPD), nodular mixed, or diffuse well differentiated lymphocytic]
